Tuesday, January 17, 2017

UPDATE 1-Biogen to pay $1.25 bln in license fees to protect MS drug

Jan 17 (Reuters) - Biogen Inc said on Tuesday it

would pay Forward Pharma A/S $1.25 billion in cash to

license the Danish company's patents covering multiple sclerosis

drugs including Biogen's...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)